Generate a tailored SOP for Dr. Florian Marks. Improve your application with a focused, well-structured draft.
Florian Marks, Ph.D., currently serves as the Deputy Director of the Epidemiology, Public Health Impact (EPIC) unit at the International Vaccine Institute (IVI). His unit is involved in comprehensive epidemiological investigations, cost-of-illness studies, and assessing vaccine effectiveness against antimicrobial resistance. With over 20 years of distinguished experience, Dr. Marks has executed large-scale, multi-center research initiatives, including the Typhoid Fever Surveillance programs in Africa. He joined IVI in 2006 after completing his doctoral degree in malaria epidemiology. Additionally, he is a Principal Research Associate at the University of Cambridge and holds an adjunct professorship at the University of Antananarivo in Madagascar. His academic training includes a Master of Public Health from the London School of Hygiene and Tropical Medicine. Dr. Marks's research focuses on late-stage clinical trials for vaccines, including a novel schistosomiasis vaccine and the typhoid conjugate vaccine, contributing essential data for WHO and Gavi's vaccine introduction initiatives. He leads efforts to leverage a network of field sites across Africa and Asia for conducting epidemiological studies and generating clinical data to improve vaccination strategies.
International Vaccine Institute • Seoul, South Korea
Leads the Epidemiology, Public Health Impact (EPIC) unit conducting studies on vaccines and public health.
University of Cambridge • Cambridge, UK
Conducting research and teaching within the Department of Medicine.
Bernhard-Nocht-Institute for Tropical Medicine • Hamburg, Germany
Involved in various research initiatives in tropical medicine.
Standard postgraduate requirements for Department of Politics and International Studies (POLIS) and related humanities departments.